KETOPROFEN SUPPOSITORIES 100 MG
KETOPROFEN : 100 MG · DIN 02237011 · PHARMEL INC
Health Canada status: CANCELLED POST MARKET
What is KETOPROFEN SUPPOSITORIES?
KETOPROFEN SUPPOSITORIES 100 MG contains KETOPROFEN : 100 MG. It is listed in the Health Canada Drug Product Database under DIN 02237011, held by PHARMEL INC, supplied as SUPPOSITORY for RECTAL administration. Health Canada currently lists it as cancelled post market, status dated 04-Jun-1998. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02237011 |
|---|---|
| Brand name | KETOPROFEN SUPPOSITORIES |
| Generic / active ingredient | KETOPROFEN : 100 MG |
| Manufacturer | PHARMEL INC |
| Strength | 100 MG |
| Dosage form | SUPPOSITORY |
| Route of administration | RECTAL |
| Schedule | Prescription |
| ATC code | M01AE03 KETOPROFEN |
| AHFS class | 28:08.04.92 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 04-Jun-1998 |
| Original market date | 1998-06-04 00:00:00 |
What can be used instead?
Other Canadian products sharing ATC code M01AE03 KETOPROFEN. 3 of 36 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| KETOPROFEN SR | 200 MG | TABLET (EXTENDED-RELEASE) | AA PHARMA INC | MARKETED | DIN 02172577 |
| KETOPROFEN-E | 100 MG | TABLET (ENTERIC-COATED) | AA PHARMA INC | MARKETED | DIN 00842664 |
| KETOPROFEN-E | 50 MG | TABLET (ENTERIC-COATED) | AA PHARMA INC | MARKETED | DIN 00790435 |
| KETOPROFEN | 50 MG | CAPSULE | AA PHARMA INC | DORMANT | DIN 00790427 |
| KETOPROFEN SUPPOSITORIES | 50 MG | SUPPOSITORY | PHARMEL INC | CANCELLED PRE MARKET | DIN 02236965 |
| KETOPROFEN-E ECT 100MG | 100 MG | TABLET (ENTERIC-COATED) | PRO DOC LIMITEE | CANCELLED POST MARKET | DIN 02084198 |
| KETOPROFEN-E ECT 50MG | 50 MG | TABLET (ENTERIC-COATED) | PRO DOC LIMITEE | CANCELLED POST MARKET | DIN 02084171 |
| KETOPROFEN-SR - SRT 200MG | 200 MG | TABLET (EXTENDED-RELEASE) | PRO DOC LIMITEE | CANCELLED POST MARKET | DIN 02210487 |
| NOVO-KETO SUPPOSITORIES 100MG | 100 MG | SUPPOSITORY | NOVOPHARM LIMITED | CANCELLED POST MARKET | DIN 02156083 |
| NOVO-KETO-EC TAB 100MG | 100 MG | TABLET (ENTERIC-COATED) | NOVOPHARM LIMITED | CANCELLED POST MARKET | DIN 01981536 |
Who else supplies KETOPROFEN worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. KETOPROFEN appears in 47 registered pack listings across 9 markets, published on 8 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.